FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

40124511000001107: Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Oct 2021. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2060221000001116 Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2060241000001114 Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has AMP Koselugo 10mg capsules (AstraZeneca UK Ltd) true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Is a Selumetinib 10mg capsules 60 capsule true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Discontinued indicator Never discontinued true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has NHS dm+d (dictionary of medicines and devices) additional monitoring indicator EMA (European Medicines Agency) monitoring true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has specific active ingredient Selumetinib hydrogen sulfate true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Selumetinib true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Koselugo 10mg capsules (AstraZeneca UK Ltd) 60 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start